Igm Biosciences Inc (IGMS) Directors and Executive Officers

Officers & Directors

Executive Officers:

1. Fred Schwarzer
Chief Executive Officer, President, and Director (Principal Executive Officer)

2. Misbah Tahir
Chief Financial Officer (Principal Financial Officer)

3. Steven Weber
Senior Vice President, Corporate Controller (Principal Accounting Officer)

Directors:

1. William Strohl, Ph.D.
Director

2. Michael Lee
Director

3. Jakob Haldor Tops e
Director

4. Felix Baker, Ph.D.
Director

5. M. Kathleen Behrens, Ph.D.
Director

6. Julie Hambleton, M.D.
Director

7. Elizabeth H.Z. Thompson, Ph.D.
Director

8. Christina Teng
Director,

Igm Biosciences Inc currently has 224 employees.

News about Igm Biosciences Inc Key Personnel

IGM Biosciences Hits a Roadblock: Autoimmunity Pipeline Programs Halted Amid $220 Million Loss as Market Soars,

IGM Biosciences Halts Key Pipeline Programs Amid Financial Struggles and Market Optimism IntroductionIn a significant strategic shift, IGM Biosciences Inc. announced it will halt further development of its promising autoimmune pipeline programs, particularly imvotamab (CD20 x CD3) and IGM-2644 (CD38 x CD3). This decision arises against a backdrop of substantial financial losses, raising questions about the company’s future amidst a vibrant healthcare market. Financial OverviewIGM Biosciences has reported a staggering cumulative net loss of $220 million for the twelve months ending in the third quarter of 2024. This financial downturn translates into a negative return on assets (ROA) of -67.58%. Furthermor...